• Topics

  • Formats

Organiser: PMLiVE

Author(s): Cuttsy + Cuttsy

A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.

There is a phrase embedded across oncology trial publications, patient information leaflets, and plain language summaries. It is used to reassure and simplify complex experiences.

‘Manageable toxicity’

It sounds reasonable. But for someone living with persistent diarrhoea, fatigue that affects their ability to work, or ongoing peripheral neuropathy, it often describes very little of what they actually experience.

Why language is never neutral

‘Manageable’ is a subjective label. It reflects a judgement, not a description.

It can mean very different things depending on clinical support, dose adjustments, and a patient’s individual circumstances. When that complexity is reduced to a single reassuring word (especially at the point of consent or treatment initiation), the real burden of side effects can be unintentionally underestimated, leaving patients unprepared for the cumulative impact over time.

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?